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Case Report Thrombocytopenia and splenomegaly: an unusual 
presentation of congenital hepatic fibrosis
Serena Botto Poala1, Gianni Bisogno2 and Raffaella Colombatti*2
Abstract
Congenital hepatic fibrosis (CHF) is a rare autosomal recessive disease that primarily affects the hepatobiliary and renal 
systems. It is characterized by hepatic fibrosis, portal hypertension, and renal cystic disease. Firm or hard hepatomegaly 
is present nearly in all patients, often with a prominent left lobe, and this is usually one of the presenting signs. The 
haematological manifestations due to hypersplenism generally arise when the other gastrointestinal manifestations 
are clearly developed. We describe the first case of CHF presenting in an otherwise healthy child, with 
thrombocytopenia and splenomegaly as the only manifestations of the disease.
Background
Congenital hepatic fibrosis (CHF) is a rare autosomal
recessive disease that primarily affects the hepatobiliary
and renal systems. It is characterized by hepatic fibrosis,
portal hypertension, and renal cystic disease [1-3]. CHF
results from a malformation of the ductal plate (the
embryological precursor of the biliary system), secondary
biliary strictures, and periportal fibrosis. This subse-
quently results in the development of portal hypertension
[4]. The exact incidence and prevalence of CHF are not
known. Only a few hundred patients with CHF have been
reported in the literature [1-4]. The disease appears in
both sporadic and familial patterns and is associated with
a wide spectrum of disorders, the most frequent of which
is autosomal recessive polycystic kidney disease
(ARPKD), but can also be an isolated condition [1,2].
The age at clinical onset and the spectrum of clinical
manifestations is highly variable because CHF has 4 dif-
ferent forms: portal hypertensive (most common), cho-
langitic, mixed, and latent. Therefore most patients
present with hepatomegaly and portal hypertension
(hematemesis or melena is the presenting sign in 30 to
70% of patients) in the first decades of life and some
patients present with cholangitis [1-5]. Patients with the
latent form generally present at an older age or are diag-
nosed as an incidental finding. Firm or hard hepatomeg-
aly is present nearly in all patients, often with a
prominent left lobe, and this is usually one of the present-
ing signs.
The hematological manifestations due to hyper-
splenism generally arise when the other gastrointestinal
manifestations are clearly developed [1-5].
We describe the first case of CHF presenting in an
healthy child, with thrombocytopenia and splenomegaly
as the only manifestations of the disease.
Case presentation
A 10-year-old girl of Caucasian origin was admitted to
our Pediatric Hematology-Oncology Outpatient Clinic
for thrombocytopenia (68 × 103/mm3) and splenomegaly.
Family history was unremarkable except for the girl's
mother being affected by microhematuria and asymp-
tomatic proteinuria. The girl's past personal medical his-
tory showed asymptomatic microhematuria since age 4.
Three weeks before the visit at our Clinic she had started
presenting headache with an itching rubeoliform rash all
over the body.
Physical examination was unremarkable except for
splenomegaly (4,5 cm). The blood count showed throm-
bocytopenia (68 × 103/mm3) while the remaining values
were within normal range (haemoglobin 13,2 g/dL, mean
corpuscular volume 75,8 fL, leukocyte 4.2 × 103/mm3,
with neutrophil 2.5 × 103/mm3, reticolocytes 41 × 103/
mm3). Kidney and liver function test were all within nor-
mal ranges: aspartate aminotransferase 34 U/L (nv 15-
40), alanine aminotransferase 24 U/L (nv 5-40), bilirubin
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21,7 umol/L (nv 1,7-17), γGT 12 U/L (nv 3-22), alkaline
phosphatase 177 IU/L (nv 56-247), creatinine 39 umol/L
(nv 27-62).
Coagulation (PT 58%, IRN 1.42, PTT 33 sec) and hap-
toglobin were normal, while Coombs Test was negative.
Serological tests for hepatitis B virus, hepatitis C virus,
HIV, cytomegalovirus, Epstein-Barr virus, parvovirus,
Toxoplasma, Rubeovirus, Herpes Simplex virus 1-2,
HHV6-7-8, Bartonella, Weil- Felix, Widal-Wright, Plas-
modium Falciparum were all negative.
Peripheral blood smear and bone marrow aspirate, per-
formed in order to exclude leukemia and metabolic dis-
eases, were normal.
The abdominal ultrasound showed splenomegaly (17
cm) with liver and kidneys of normal size and echogenic-
ity. A Doppler ultrasound showed a normal portal blood
flow. The thorax x-Ray was normal.
Two months later, due to the persistence of the throm-
bocytopenia (57 × 103/mm3), in order to exclude an auto-
immune disease, we evaluated antiplatelet antibodies,
Antinuclear (ANA), antiDNA, anti-extractable nuclear
antigen (ENA), antimitochondrial and anti parietal cell
(APCA) antibodies, anti muscle antibody which all
resulted negative.
Three months after the initial evaluation, physical
examination, thrombocytopenia and abdominal ultra-
sound remained unchanged. The child persisted in good
general conditions.
Six months later, due to the persistence of both the
thrombocytopenia (50 × 103/mm3) and the splenomegaly,
an abdominal CT scan was performed confirming the
splenomegaly but showing also an ectasia of the portal
vein, hepatomegaly -with the left liver lobe reaching the
left posterior axillary region- with dilatation of the intra-
hepatic bile ducts, mainly in the right liver lobe.
Due to the results of the abdominal CT scan, the girl
was admitted to the Pediatric Gastroenterology and
Hepatology Unit for further investigations of a possible
liver pathology. Ceruloplasmin 0,29 g/l (nv 0,22-0,6),
cupremia 9,9 umol/l (nv 14-25), cupruria 0,543 umol/24 h
(nv 0,047-0,55), α fetoprotein 1,3 ug/l, α1- antitrypsin 135
mg/dl were all within normal ranges. An abdomen MRI
revealed reduction of the volume of the right liver lobe,
hypertrophy of the lateral segment of the left liver lobe
and splenomegaly (Figure 1). Cholangio-MRI revealed
slight dilatation of the biliary tract of the right lobe; the
hepatic duct and the choledoch were normal (Figure 2).
Hepatobiliary scintigraphy showed hepatomegaly of the
left lobe, with a normal captation of the radionuclide;
after the first forty-five minute there was a feeble visual-
ization of some parts of the biliary tract and of the bowel;
an elevated parenchymal activity persisted after the first
hour of acquisition. After two hours from a fat meal there
was an elevated bowel activity; the outflow of the left lobe
was complete, while there was a persistence of the activity
in the lateral portion of the right lobe. Gastroscopy
revealed esophagogastric varices. The liver biopsy, per-
formed on both the right and the left lobe, demonstrated
the characteristic abnormalities of congenital hepatic
fibrosis (persistence of bile ducts remnants, abnormal
branching of the intrahepatic portal veins and fibrosis of
the portal tracts) on both lobes; the kidney biopsy was
normal.
Figure 1 Abdomen MRI showing reduction of the volume of the 
right liver lobe, hypertrophy of the lateral segment of the left liv-
er lobe and splenomegaly.
Figure 2 Cholangio MRI showing slight dilatation of the biliary 
tract of the right lobe, normal hepatic duct and choledoch.Poala et al. Orphanet Journal of Rare Diseases 2010, 5:4
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Discussion
CHF is a very rare disease with heterogeneous clinical
manifestations [1-5].
The case that we describe is the first reported case of
CHF with splenomegaly and thrombocytopenia as the
only presenting signs. Hepatomegaly on physical exami-
nation has been described in all the reported cases of
CHF. The absence of this sign and the normality of liver
function in our patient is surprising and contributed to
the delay in the diagnosis of CHF. Despite the lack of
physical (hepatomegaly) and echocardiographic
(increased echogenicity of the liver) signs of CHF, on MRI
she displayed some of the common features of CHF[6]:
abnormal large left lobe of the liver, enlarged spleen
accompanied by slight dilatation of the intrahepatic bile
ducts in the right lobe. Moreover, the girl showed the
signs of portal hypertension, one of the prominent mani-
festations of CHF: splenomegaly with an ectasia of the
portal vein and esophageal varices. Therefore, in our
patient the suspect of primary hepatic pathology arose
with the abdominal CT scan, but the final diagnosis of
CHF was histopathologic, with the liver biopsy showing
the typical histological abnormalities of CHF [6].
The absence of frank cystic dilatation of bile ducts on
Colangio-MRI excluded Caroli's disease (a congenital dis-
order characterized by cystic dilatation of intrahepatic
bile ducts without CHF) and Caroli's syndrome (the asso-
ciation of CHF and macroscopic liver cysts in continuity
with the bile ducts).
The hematologic manifestations of CHF generally arise
after the development of hypersplenism, secondary to
portal hypertension, and include anemia, thrombocy-
topenia and leucopenia. To our knowledge, features of
hypersplenism in children with CHF have alwa ys been
associated with hepatomegaly and usually accompany
other complex gastrointestinal manifestations, like bleed-
ing from esophageal varices [7-10]. A child with mainly
hematologic symptoms mimicking acute leukemia and
diagnosed with CHF has been described, but he had a
three-lineage cytopenia coupled with both splenomegaly
and hepatomegaly [11]. Other children with pancytope-
nia have also been reported, but again it was associated
with important hepatomegaly and alteration of hepatic
function [7,10].
Our child had microhematuria since age 4 and the
child's mother had microhematruria and proteinuria
since 20 years of age. The child had also enlarged kidneys
with normal echogenicity on abdominal ultrasound, but
the kidney biopsy was normal. Isolated microhematuria
and tubular defects leading to proteinuria are usually not
the typical manifestations of renal involvement in CHF
and other ciliopathies. In fact, CHF is an hepatic fibrocys-
tic disease caused by defective ciliary proteins, called "cil-
iopathies" [12]. In ciliopathies, the liver and the kidneys
are commonly affected organs, because primary cilia host
critical signal transduction pathways and also sense
chemical, osmotic, and mechanical stimuli such as lumi-
nal fluid flow, and regulate important cellular functions
including proliferation and maintenance of planar cell
polarity and mitotic spindle orientation to ensure normal
epithelial function and normal diameter of tubular struc-
tures such as renal and biliary ducts. In ciliopathies, the
kidneys display pathologies ranging from a urinary con-
centration defect in normal appearing kidneys to cystic
dysplastic kidneys. Nevertheless, since an increasing
number of human disorders associated with ciliary dys-
function is just being unraveled, new discrete clinical
entities might be defined in the future [13]. Moreover,
further follow-up of the girl and the mother might clarify
the renal involvement in both of them, since renal dam-
age can progress with aging.
Thrombocytopenia is a very common problem that
pediatricians have to face in their clinical practice. It is
usually an acute episode caused by increased destruction
during Idiopathic Thrombocytopenic Purpura (ITP) and
resolves spontaneously. When thrombocytopenia is per-
sistent, more rare causes must be considered, whether
autoimmune, metabolic or hereditary [14].
Our case demonstrates that when the most common
causes of thrombocytopenia have been ruled out, other
rare conditions including liver diseases must be consid-
ered. CHF must be kept in mind when splenomegaly is
present even if hepatomegaly is not part of the physical
examination. In our case the hypertrophy of the left
hepatic lobe hepatomegaly was visible only on the CT
scan, developing behind the spleen towards the left axil-
lary region and not toward the lower abdomen. Despite
the scarce symptoms and signs shown by the child, she
already had esophageal varices showing a progression of
the disease. Therefore, our case suggests that, in patients
with persistent thrombocytopenia and splenomegaly, if
autoimmune (ITP) disorders have been excluded, the
abdominal CT scan might help in defining the diagnosis.
Conclusions
In conclusion, CHF diagnosis should be considered by
pediatricians in children with thrombocytopenia and
splenomegaly as a rare, but still possible, cause of the
signs and symptoms, even in the absence of hepatomeg-
aly. Moreover, our case demonstrates that CHF can pres-
ent in childhood with mild hematologic manifestations,
without hepatomegaly on physical examination.
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